Budur Kumar's most recent trade in Harmony Biosciences Holdings Inc was a trade of 35,852 Common Stock done at an average price of $43.1 . Disclosure was reported to the exchange on Sept. 16, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 43.05 per share. | 16 Sep 2026 | 35,852 | 13,115 | - | 43.1 | 1,543,590 | Common Stock |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2026 | 25,446 | 37,500 | - | - | Stock Option | |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.27 per share. | 16 Sep 2026 | 25,446 | 48,967 | - | 30.3 | 770,250 | Common Stock |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2026 | 10,406 | 18,594 | - | - | Stock Option | |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.69 per share. | 16 Sep 2026 | 10,406 | 23,521 | - | 30.7 | 319,360 | Common Stock |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 43.01 per share. | 16 Sep 2026 | 1,800 | 13,115 | - | 43.0 | 77,426 | Common Stock |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.69 per share. | 16 Sep 2026 | 900 | 14,015 | - | 30.7 | 27,621 | Common Stock |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2026 | 900 | 63,346 | - | - | Stock Option | |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2026 | 900 | 29,400 | - | - | Stock Option | |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.27 per share. | 16 Sep 2026 | 900 | 14,915 | - | 30.3 | 27,243 | Common Stock |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 43.00 per share. | 16 Sep 2026 | 800 | 13,115 | - | 43 | 34,400 | Common Stock |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2026 | 400 | 62,946 | - | - | Stock Option | |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Sep 2026 | 400 | 29,000 | - | - | Stock Option | |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.27 per share. | 16 Sep 2026 | 400 | 13,915 | - | 30.3 | 12,108 | Common Stock |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.69 per share. | 16 Sep 2026 | 400 | 13,515 | - | 30.7 | 12,276 | Common Stock |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 43.10 per share. | 04 Sep 2026 | 22,954 | 13,115 | - | 43.1 | 989,350 | Common Stock |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2026 | 12,200 | 30,300 | - | - | Stock Option | |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.69 per share. | 04 Sep 2026 | 12,200 | 25,315 | - | 30.7 | 374,418 | Common Stock |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Sep 2026 | 10,754 | 64,246 | - | - | Stock Option | |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.27 per share. | 04 Sep 2026 | 10,754 | 36,069 | - | 30.3 | 325,524 | Common Stock |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 41.98 per share. | 04 Sep 2026 | 5,500 | 18,615 | - | 42.0 | 230,911 | Common Stock |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 42.25 per share. | 04 Sep 2026 | 4,500 | 14,115 | - | 42.2 | 190,114 | Common Stock |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Sale of securities on an exchange or to another person at price $ 42.80 per share. | 04 Sep 2026 | 1,000 | 13,115 | - | 42.8 | 42,795 | Common Stock |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2026 | 18,750 | 32,997 | - | 0 | Common Stock | |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2026 | 18,750 | 37,500 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 31.83 per share. | 01 May 2026 | 8,882 | 24,115 | - | 31.8 | 282,714 | Common Stock |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2026 | 42,600 | 42,600 | - | - | Stock Option | |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jan 2026 | 12,200 | 12,200 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2026 | 2,662 | 2,662 | - | 0 | Common Stock | |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2026 | 2,662 | 7,988 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2026 | 2,188 | 4,175 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jan 2026 | 2,188 | 2,188 | - | 0 | Common Stock | |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.82 per share. | 22 Jan 2026 | 1,372 | 1,290 | - | 36.8 | 50,517 | Common Stock |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.82 per share. | 22 Jan 2026 | 1,153 | 1,035 | - | 36.8 | 42,453 | Common Stock |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 18,750 | 18,750 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 18,750 | 18,750 | - | 0 | Common Stock | |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.86 per share. | 01 May 2025 | 8,869 | 9,881 | - | 29.9 | 264,828 | Common Stock |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 37,400 | 37,400 | - | - | Stock Option | |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 10,650 | 10,650 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jan 2025 | 2,187 | 6,563 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jan 2025 | 2,187 | 2,187 | - | 0 | Common Stock | |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.01 per share. | 24 Jan 2025 | 1,151 | 1,036 | - | 38.0 | 43,750 | Common Stock |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 75,000 | 75,000 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 75,000 | 75,000 | - | - | Stock Option | |
| Harmony Biosciences Holdings Inc | Budur Kumar | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 42,500 | 42,500 | - | - | Stock Option | |
| Harmony Biosciences Holdings Inc | Kumar Budur | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 8,750 | 8,750 | - | - | Restricted Stock Units |